Volume : 08, Issue : 11, November – 2021
Title:
13.CURRENT DIAGNOSTIC AND THERAPEUTIC STRATEGIES FOR COVID-19- A REVIEW
Authors :
Sonam Sasi*, Dr. Subhash Chandran M P, Dr. Prashob G R, Shilpa Suresh, Rohini L M
Abstract :
The outbreak and spread of the novel coronavirus disease 2019 (COVID-19) with pandemic features, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have greatly threatened global public health. Given the perniciousness of COVID-19 pandemic, acquiring a deeper understanding of this viral illness is critical for the development of new vaccines and therapeutic options. In this review, we introduce the systematic evolution of coronaviruses and the structural characteristics of SARS-CoV-2. We also summarize the current diagnostic tools and therapeutic strategies for COVID-19.
Keywords: Diagnosis; Treatment; COVID-19; Coronavirus; SARS-CoV-2.
Cite This Article:
Please cite this article in press Sonam Sasi et al, Current Diagnostic And Therapeutic Strategies For Covid-19- A Review., Indo Am. J. P. Sci, 2021; 08(11).
Number of Downloads : 10
References:
1. Jin Y-H, Cai L, Cheng Z-S, Cheng H, Deng T, Fan Y-P, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7:4.
2. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. Te species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 5, 536–544 (2020).
3. A.E. Gorbalenya, S.C. Baker, R.S. Baric, et al., The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2, Nat. Microbiol. 5 (2020) 536–544.
4. K. Kupferschmidt, J. Cohen, Will novel virus go pandemic or be contained? Journal Pre-proof 19 Science 367 (2020) 610−611.
5. M.U. Mirza, M. Froeyen, Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase, J. Pharm. Anal. 10 (2020) DOI: 10.1016/j.jpha.2020.04.008.
6. N. Navas, J. Hermosilla, A. Torrente-López, et al., Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes, J. Pharm. Anal. 10 (2020) DOI: 10.1016/j.jpha.2020.06.003.
7. Wang, D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. J. Am. Med. Assoc. 323, 1061–1069 (2020).
8. Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19 (Centers for Disease Control and Prevention, 2020); https:// www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html.
9. Ai, T. et al. Correlation of chest CT and RT–PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology 296, E32–E40 (2020).
10. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020 200642. doi: https://doi.org/10.1148/radiol.2020200642.
11. Wang, B., Li, R., Lu, Z. & Huang, Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging 12, 6049–6057 (2020).
12. Loefelholz, M. J. & Tang, Y. W. Laboratory diagnosis of emerging human coronavirus infections—the state of the art. Emerg. Microbes Infect. 9, 747–756 (2020).
13. Winichakoon, P. et al. Negative nasopharyngeal and oropharyngeal swabs do not rule out COVID-19. J. Clin. Microbiol. 58, e00297-20 (2020).
14. Pan, Y. et al. Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients. J. Infect. 81, e28–e32 (2020).
15. Lin, D. et al. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak. Eur. J. Clin. Microbiol. Infect. Dis. 39, 2271–2277 (2020).
16. Lipsitch, M., Swerdlow, D. L. & Finelli, L. Defning the epidemiology of Covid-19—studies needed. N. Engl. J. Med. 382, 1194–1196 (2020).